The cent
Post-infection gut dysbiosis drives systemic inflammation, leaky gut, and immune dysregulation all of which amplify fatigue, cognitive impairment, and mood instability.3 BPC-157 has been shown in multiple animal studies to: Accelerate healing of the intestinal epithelium4 Reduce gut inflammation and restore tight junction integrity5 Modulate the vagus nerve, which connects gut function to brain and immune signaling6 For long COVID patients dealing with GI symptoms, food intolerances, or fatigue that tracks with gut dysfunction, this mechanism is directly relevant
+ (): , GHK-Cu
(2015) Cutaneous microbiome activity and vitamin B12 in acne development, Science Translational Medicine.
Not for human consumption, clinical, diagnostic, veterinary, or therapeutic use
Tirzepatide's dual GIP/GLP-1 activation produces stronger appetite suppression than semaglutide alone, with patients typically experiencing faster fat loss and improved metabolic markers like fasting glucose and triglycerides